Pink SheetThe US FDA’s Center for Drug Evaluation and Research cleared two new molecular entities in the last days of September, both for rare diseases – intrahepatic cholangiocarcinoma for Taiho Pharmaceutica
Pink SheetCorMedix Inc. is gearing up to try for approval of its catheter lock solution Neutrolin under the US Food and Drug Administration’s Limited Population Pathway for Antibacterial and Antifungal Drugs (
ScripStrategic shifts by Merrimack Pharmaceuticals Inc. and Vical Inc. took different turns during the last week of August, which was predictably quiet ahead of the long Labor Day weekend in the US in
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Vertex Gene-Editing Play Inc